€19.80
0.25%
Paris, Oct 02, 05:35 pm CEST. Closed.
ISIN
FR0000061129
Symbol
BOI

Boiron Stock price

€19.80
-6.40 24.43% 1M
-8.20 29.29% 6M
-10.50 34.65% YTD
-7.10 26.39% 1Y
-23.54 54.32% 3Y
-13.51 40.56% 5Y
-53.79 73.09% 10Y
+5.95 43.00% 20Y
Paris, Closing price Fri, Oct 02 2026
-0.05 0.25%
ISIN
FR0000061129
Symbol
BOI
Industry

Is Boiron a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.

Key metrics

Basic
Market capitalization
€347.7m
Enterprise Value
€313.8m
Net debt
positive
Cash
€57.8m
Shares outstanding
17.4m
Valuation
P/E
13.1
P/S | estimate
0.7 | 0.7
EV/Sales | estimate
0.6 | 0.6
EV/FCF | ex SBC
21.5 | -
P/B
0.9
Dividends
DPS
€1.35
Yield 1Y | 5Y
6.8% | 3.5%
Growth 1Y | 5Y
12.5% | 12.1%
Payout 1Y | 3Y
63.8% | 300.5%
Increased
1 Year
Financials
Revenue | estimate
€495.8m | €528.2m
EBITDA
€52.6m
EBIT
€35.5m
Net Income
€26.2m
Free Cash Flow | ex SBC
€14.6m | -
Growth
Revenue | estimate
-1.8% | 5.4%
EBITDA
-25.9%
EBIT
33.8%
Net Income
35.2%
Free Cash Flow
-60.9%
Margin
Gross
72.2%
EBITDA
10.6%
EBIT
7.2%
Net
5.3%
Free Cash Flow | ex SBC
2.9% | -
Financial Health
Equity Ratio
65.2%
Return on Equity
8.3%
ROCE
7.8%
ROIC
5.8%
Debt/Equity
0.1
More
EPS
€1.5
FCF per Share
€0.8
Short interest
-
Employees
2k
Rev per Employee
€200.0k

Boiron Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Boiron forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a Boiron forecast:

Buy
80%
Hold
20%

Financial data from Boiron

Jun '26
+/-
%
496 496
2% 2%
100%
- Direct Costs 138 138
4% 4%
28%
358 358
4% 4%
72%
- Selling and Administrative Expenses 255 255
2% 2%
51%
- Research and Development Expense 6 6
5% 5%
1%
53 53
26% 26%
11%
- Depreciation and Amortization 17 17
62% 62%
3%
EBIT (Operating Income) EBIT 36 36
34% 34%
7%
Net Profit 26 26
35% 35%
5%

In millions EUR.

Don't miss a Thing! We will send you all news about Boiron directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Boiron SA engages in the manufacturing and selling homeopathic medicines. The firm develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. The company also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.

Head office France
CEO Mr. Boiron
Employees 2,499
Website www.boiron.fr

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today